Scientific Reports (Mar 2022)
CRF07_BC is associated with slow HIV disease progression in Chinese patients
- Jingrong Ye,
- Jing Chen,
- Juan Wang,
- Yuncong Wang,
- Hui Xing,
- Fengting Yu,
- Lifeng Liu,
- Yang Han,
- Huihuang Huang,
- Yi Feng,
- Yuhua Ruan,
- Minna Zheng,
- Xinli Lu,
- Xiaoli Guo,
- Hong Yang,
- Qi Guo,
- Yi Lin,
- Jianjun Wu,
- Shouli Wu,
- Yilong Tang,
- Xiaoguang Sun,
- Xiaobai Zou,
- Guolong Yu,
- Jianjun Li,
- Quanhua Zhou,
- Ling Su,
- Lincai Zhang,
- Zhan Gao,
- Ruolei Xin,
- Shufang He,
- Conghui Xu,
- Mingqiang Hao,
- Yinxiao Hao,
- Xianlong Ren,
- Jie Li,
- Lishi Bai,
- Tianjun Jiang,
- Tong Zhang,
- Yiming Shao,
- Hongyan Lu
Affiliations
- Jingrong Ye
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Jing Chen
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Juan Wang
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Yuncong Wang
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Hui Xing
- Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC
- Fengting Yu
- Clinical and Research Center of Infectious Diseases, Beijing DiTan Hospital, Capital Medical University
- Lifeng Liu
- Center for Infectious Diseases, Beijing YouAn Hospital, Capital Medical University
- Yang Han
- Department of Infectious Disease, Peking Union Medical College Hospital
- Huihuang Huang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital of China
- Yi Feng
- Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC
- Yuhua Ruan
- Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC
- Minna Zheng
- Institute for HIV/AIDS and STD Prevention and Control, Tianjin CDC
- Xinli Lu
- Institute for HIV/AIDS and STD Prevention and Control, Hebei CDC
- Xiaoli Guo
- Institute for HIV/AIDS and STD Prevention and Control, Shanxi CDC
- Hong Yang
- Institute for HIV/AIDS and STD Prevention and Control, Inner Mongolia CDC
- Qi Guo
- Institute for HIV/AIDS and STD Prevention and Control, Jilin CDC
- Yi Lin
- Institute for HIV/AIDS and STD Prevention and Control, Shanghai CDC
- Jianjun Wu
- Institute for HIV/AIDS and STD Prevention and Control, Anhui CDC
- Shouli Wu
- Institute for HIV/AIDS and STD Prevention and Control, Fujian CDC
- Yilong Tang
- Institute for HIV/AIDS and STD Prevention and Control, Jiangxi CDC
- Xiaoguang Sun
- Institute for HIV/AIDS and STD Prevention and Control, Shandong CDC
- Xiaobai Zou
- Institute for HIV/AIDS and STD Prevention and Control, Hunan CDC
- Guolong Yu
- Institute for HIV/AIDS and STD Prevention and Control, Guangdong CDC
- Jianjun Li
- Institute for HIV/AIDS and STD Prevention and Control, Guangxi CDC
- Quanhua Zhou
- Institute for HIV/AIDS and STD Prevention and Control, Chongqing CDC
- Ling Su
- Institute for HIV/AIDS and STD Prevention and Control, Sichuan CDC
- Lincai Zhang
- Institute for HIV/AIDS and STD Prevention and Control, Gansu CDC
- Zhan Gao
- Beijing Red Cross Blood Center
- Ruolei Xin
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Shufang He
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Conghui Xu
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Mingqiang Hao
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Yinxiao Hao
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Xianlong Ren
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Jie Li
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Lishi Bai
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- Tianjun Jiang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital of China
- Tong Zhang
- Center for Infectious Diseases, Beijing YouAn Hospital, Capital Medical University
- Yiming Shao
- Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC
- Hongyan Lu
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine
- DOI
- https://doi.org/10.1038/s41598-022-07518-4
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 11
Abstract
Abstract HIV subtypes convey important epidemiological information and possibly influence the rate of disease progression. In this study, HIV disease progression in patients infected with CRF01_AE, CRF07_BC, and subtype B was compared in the largest HIV molecular epidemiology study ever done in China. A national data set of HIV pol sequences was assembled by pooling sequences from public databases and the Beijing HIV laboratory network. Logistic regression was used to assess factors associated with the risk of AIDS at diagnosis ([AIDSAD], defined as a CD4 count < 200 cells/µL) in patients with HIV subtype B, CRF01_AE, and CRF07_BC. Of the 20,663 sequences, 9,156 (44.3%) were CRF01_AE. CRF07_BC was responsible for 28.3% of infections, followed by B (13.9%). In multivariable analysis, the risk of AIDSAD differed significantly according to HIV subtype (OR for CRF07_BC vs. B: 0.46, 95% CI 0.39─0.53), age (OR for ≥ 65 years vs. < 18 years: 4.3 95% CI 1.81─11.8), and transmission risk groups (OR for men who have sex with men vs. heterosexuals: 0.67 95% CI 0.6─0.75). These findings suggest that HIV diversity in China is constantly evolving and gaining in complexity. CRF07_BC is less pathogenic than subtype B, while CRF01_AE is as pathogenic as B.